These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 26303376)

  • 1. Editorial Comment to Reassessment of the risk factors for biochemical recurrence in D'Amico intermediate-risk prostate cancer treated using radical prostatectomy.
    Mearini L
    Int J Urol; 2015 Nov; 22(11):1035-6. PubMed ID: 26303376
    [No Abstract]   [Full Text] [Related]  

  • 2. Reassessment of the risk factors for biochemical recurrence in D'Amico intermediate-risk prostate cancer treated using radical prostatectomy.
    Narita S; Mitsuzuka K; Tsuchiya N; Koie T; Kawamura S; Ohyama C; Tochigi T; Yamaguchi T; Arai Y; Habuchi T;
    Int J Urol; 2015 Nov; 22(11):1029-35. PubMed ID: 26290306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Editorial comment on: systematic assessment of the ability of the number and percentage of positive biopsy cores to predict pathologic stage and biochemical recurrence after radical prostatectomy.
    Greene DR
    Eur Urol; 2007 Sep; 52(3):744-5. PubMed ID: 17350749
    [No Abstract]   [Full Text] [Related]  

  • 4. Editorial comment on: systematic assessment of the ability of the number and percentage of positive biopsy cores to predict pathologic stage and biochemical recurrence after radical prostatectomy.
    Trpkov K
    Eur Urol; 2007 Sep; 52(3):743-4. PubMed ID: 17350751
    [No Abstract]   [Full Text] [Related]  

  • 5. Ability of 2 pretreatment risk assessment methods to predict prostate cancer recurrence after radical prostatectomy: data from CaPSURE.
    Mitchell JA; Cooperberg MR; Elkin EP; Lubeck DP; Mehta SS; Kane CJ; Carroll PR
    J Urol; 2005 Apr; 173(4):1126-31. PubMed ID: 15758720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Editorial Comment to Postoperative prostate-specific antigen nadir improves accuracy for predicting biochemical recurrence after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) and Duke Prostate Center databases.
    Viney R
    Int J Urol; 2010 Nov; 17(11):922-3. PubMed ID: 20969639
    [No Abstract]   [Full Text] [Related]  

  • 7. [Radical prostatectomy and radiation therapy for high-risk prostate cancer: An update].
    Lei JH; Chen YJ; Liu LR; Wei Q
    Zhonghua Nan Ke Xue; 2015 Jul; 21(7):663-6. PubMed ID: 26333232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term outcomes of open radical retropubic prostatectomy for clinically localized prostate cancer in the prostate-specific antigen era.
    Dorin RP; Daneshmand S; Lassoff MA; Cai J; Skinner DG; Lieskovsky G
    Urology; 2012 Mar; 79(3):626-31. PubMed ID: 22245303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The risk of biochemical recurrence for intermediate-risk prostate cancer after radical prostatectomy.
    Kurbegovic S; Berg KD; Thomsen FB; Gruschy L; Iversen P; Brasso K; Røder MA
    Scand J Urol; 2017 Dec; 51(6):450-456. PubMed ID: 28762283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Importance of prostate volume in the stratification of patients with intermediate-risk prostate cancer.
    Moschini M; Gandaglia G; Suardi N; Fossati N; Cucchiara V; Damiano R; Cantiello F; Shariat SF; Montorsi F; Briganti A
    Int J Urol; 2015 Jun; 22(6):555-61. PubMed ID: 25783998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Editorial comment.
    Morgan TM; Feng FY
    Urology; 2014 Dec; 84(6):1432-3. PubMed ID: 25432833
    [No Abstract]   [Full Text] [Related]  

  • 12. Words of wisdom. Re: Comparative effectiveness of robot-assisted versus open radical prostatectomy cancer control.
    Mathieu R; Bensalah K
    Eur Urol; 2015 Mar; 67(3):589. PubMed ID: 25760412
    [No Abstract]   [Full Text] [Related]  

  • 13. Editorial comment on: Oncological and functional results of antegrade radical retropubic prostatectomy for the treatment of clinically localised prostate cancer.
    van der Poel HG
    Eur Urol; 2008 Mar; 53(3):561-2. PubMed ID: 17683855
    [No Abstract]   [Full Text] [Related]  

  • 14. Does surgical delay for radical prostatectomy affect biochemical recurrence? A retrospective analysis from a Canadian cohort.
    Zanaty M; Alnazari M; Ajib K; Lawson K; Azizi M; Rajih E; Alenizi A; Hueber PA; Tolmier C; Meskawi M; Saad F; Pompe RS; Karakiewicz PI; El-Hakim A; Zorn KC
    World J Urol; 2018 Jan; 36(1):1-6. PubMed ID: 29052761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What are the factors associated with short prostate specific antigen doubling time after radical prostatectomy? A report from the SEARCH database group.
    Teeter AE; Bañez LL; Presti JC; Aronson WJ; Terris MK; Kane CJ; Amling CL; Freedland SJ;
    J Urol; 2008 Nov; 180(5):1980-4; discussion 1985. PubMed ID: 18801519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of statin use on clinicopathological characteristics of localized prostate cancer and outcomes obtained after radical prostatectomy: a single center study.
    Cattarino S; Seisen T; Drouin SJ; Renard-Penna R; Leon P; Comperat E; Mozer P; Cussenot O; Rouprêt M
    Can J Urol; 2015 Apr; 22(2):7703-8. PubMed ID: 25891333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncologic outcomes at 10 years following robotic radical prostatectomy.
    Diaz M; Peabody JO; Kapoor V; Sammon J; Rogers CG; Stricker H; Lane Z; Gupta N; Bhandari M; Menon M
    Eur Urol; 2015 Jun; 67(6):1168-1176. PubMed ID: 24996687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Length of positive surgical margin after radical prostatectomy as a predictor of biochemical recurrence.
    Shikanov S; Song J; Royce C; Al-Ahmadie H; Zorn K; Steinberg G; Zagaja G; Shalhav A; Eggener S
    J Urol; 2009 Jul; 182(1):139-44. PubMed ID: 19450829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adverse Pathologic Features at Radical Prostatectomy: Effect of Preoperative Risk on Oncologic Outcomes.
    Imnadze M; Sjoberg DD; Vickers AJ
    Eur Urol; 2016 Jan; 69(1):143-8. PubMed ID: 25913389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Editorial comment on: Risk-adjusted hazard rates of biochemical recurrence for prostate cancer patients after radical prostatectomy.
    Hakenberg OW
    Eur Urol; 2009 Feb; 55(2):421. PubMed ID: 19027224
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.